Phase II randomised study of maintenance treatment with bevacizumab or bevacizumab plus metronomic chemotherapy after first-line induction with FOLFOXIRI plus Bevacizumab for metastatic colorectal cancer patients: the MOMA trial
Titel:
Phase II randomised study of maintenance treatment with bevacizumab or bevacizumab plus metronomic chemotherapy after first-line induction with FOLFOXIRI plus Bevacizumab for metastatic colorectal cancer patients: the MOMA trial
Auteur:
Cremolini, Chiara Marmorino, Federica Bergamo, Francesca Aprile, Giuseppe Salvatore, Lisa Masi, Gianluca Dell’Aquila, Emanuela Antoniotti, Carlotta Murgioni, Sabina Allegrini, Giacomo Borelli, Beatrice Gemma, Donatello Casagrande, Mariaelena Granetto, Cristina Delfanti, Sara Di Donato, Samantha Schirripa, Marta Sensi, Elisa Tonini, Giuseppe Lonardi, Sara Fontanini, Gabriella Boni, Luca Falcone, Alfredo